Long‐Term Retention Rates of Lamotrigine, Gabapentin, and Topiramate in Chronic Epilepsy

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Epilepsia

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1499-1654.2000.001592.xPMID 11114218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgical treatment of epilepsies.

  2002cited by this paper
• The Long‐Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic Epilepsy

  1999cited by this paper
• The Mayo Clinic–Canadian cooperative trial of sulfasalazine in active multiple sclerosis

  1999cited by this paper
• Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic

  1999cited by this paper
• New drugs for epilepsy.

  1998cited by this paper
• Is the underlying cause of epilepsy a major prognostic factor for recurrence?

  1998cited by this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cited by this paper
• Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome

  1996cited by this paper
• Guidelines for ATC classification and DDD assignment

  1996cited by this paper
• The impact of new antiepileptic drugs on the prognosis of epilepsy

  1996cited by this paper
• Some Aspects of Prognosis in the Epilepsies: A Review

  1993cited by this paper
• Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy

  1993cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Evaluation of Adverse Drug Effects of Anti-Epileptic Drugs in Tertiary Care Hospitals

  2026cites this paper
• Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety

  2025cites this paper
• Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program

  2021cites this paper
• Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

  2020cites this paper
• A Perspective on Quality of Life

  2020cites this paper
• Real‐world experience with direct brain‐responsive neurostimulation for focal onset seizures

  2020cites this paper
• Ketogenic Diet Therapy in Infants: Efficacy and Tolerability.

  2018cites this paper
• Real world experience with lacosamide monotherapy- a single center 1-year follow-up study.

  2018cites this paper
• Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US

  2018cites this paper
• Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis

  2017cites this paper
• A review of medication adherence in people with epilepsy

  2017cites this paper
• Comparative analysis of cost and efficacy for mono and dual therapy of antiepileptics among children

  2017cites this paper
• Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long‐term study of 136 patients

  2017cites this paper
• Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center.

  2017cites this paper
• Level of physical activity and aerobic capacity associate with quality of life in patients with temporal lobe epilepsy

  2017cites this paper
• Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market

  2017cites this paper
• Clinical experience with adjunctive perampanel in adult patients with uncontrolled epilepsy: A UK and Ireland multicentre study.

  2016cites this paper
• Retention rates of levetiraceram in Chinese children and adolescents with epilepsy.

  2015influential citation
• Closing the Treatment Gap in Drug-resistant Epilepsy – A Japanese Success Story

  2015cites this paper
• Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients

  2015cites this paper
• Evidence for Efficacy of Combination of Antiepileptic Drugs in Treatment of Epilepsy

  2015cites this paper
• Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study

  2015cites this paper
• Galantamine treatment in outpatients with mild Alzheimer's disease

  2014cites this paper
• Long term retention of retigabine in a cohort of people with drug resistant epilepsy.

  2014cites this paper
• The RNS System: responsive cortical stimulation for the treatment of refractory partial epilepsy

  2014cites this paper
• Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

  2013cites this paper
• The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre

  2013cites this paper
• Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation.

  2013cites this paper
• Long-term Safety of Gastroretentive Gabapentin in Postherpetic Neuralgia Patients

  2013cites this paper
• The Long-Term Safety of Antiepileptic Drugs

  2013cites this paper
• Outcomes of Sustained-Release Formulation of Valproate and Topiramate Monotherapy in Patients with Epilepsy: A Multi-Centre, Cohort Study

  2012cites this paper
• Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: a multicentre study in epilepsy clinics in the United Kingdom (UK).

  2012cites this paper
• Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin.

  2012cites this paper
• The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre.

  2011cites this paper
• Persistence and Safety of Topiramate Treatment in Adults and Children with Epilepsy: A retrospective cohort study

  2011cites this paper
• Currently available antiepileptic drugs

  2011cites this paper
• Vagus nerve stimulation for epilepsy; additional work commissioned to encompass an update of evidence

  2011cites this paper
• Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta‐analysis

  2011cites this paper
• EPILEPSY SURGERY AND ELECTRONIC DEVICES

  2010cites this paper
• Measuring outcomes of treatment with antiepileptic drugs in clinical trials.

  2010cites this paper
• Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.

  2009cites this paper
• The impact of side effects on long-term retention in three new antiepileptic drugs.

  2009cites this paper
• Retention rates of new antiepileptic drugs in localization‐related epilepsy: a single‐center study

  2009influential citation
• Interpreting regulatory trials in epilepsy

  2009cites this paper
• The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre.

  2009cites this paper
• Langzeiterfahrungen mit Levetiracteam über einen Beobachtungszeitraum von fünf Jahren

  2009cites this paper
• CNS Adverse Events Associated with Antiepileptic Drugs

  2008cites this paper
• A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy.

  2008cites this paper
• Designing Clinical Trials to Assess Antiepileptic Drugs as Monotherapy

  2008cites this paper
• Effects of a static magnetic field on audiogenic seizures in black Swiss mice.

  2008cites this paper
• Long‐term safety and efficacy of zonisamide in patients with refractory partial‐onset epilepsy

  2008cites this paper
• [A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study].

  2008cites this paper
• Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

  2008cites this paper
• Retentionsraten bei kontrollierten Antiepileptika-Studien

  2008cites this paper
• Use and safety profile of antiepileptic drugs in Italy

  2007cites this paper
• Topiramate in the treatment of partial and generalized epilepsy

  2007cites this paper
• Importance of competing risks in the analysis of anti-epileptic drug failure

  2007cites this paper
• Epilepsy: Mechanisms of Drug Action and Clinical Treatment

  2007cites this paper
• Retention rate of levetiracetam in children with intractable epilepsy at 1 year.

  2007cites this paper
• Comparative retention rates and long-term tolerability of new antiepileptic drugs.

  2007cites this paper
• Efficacy and Safety of Levetiracetam as Adjunctive Treatment in a Multicenter Open-Label Single-Arm Trial in Korean Patients with Refractory Partial Epilepsy: Over 1-Year Follow-Up

  2007cites this paper
• The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies.

  2007cites this paper
• Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.

  2007cites this paper
• Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.

  2007cites this paper
• Role of valproate across the ages. Treatment of epilepsy in children

  2006cites this paper
• Uno studio di drug utilisation delle statine nella recente prassi terapeutica italiana

  2006cites this paper
• Levetiracetam: a long‐term follow‐up study of efficacy and safety

  2006cites this paper
• Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long‐term studies?

  2006cites this paper
• Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.

  2005cites this paper
• When Do Children Convert from Liquid Antiretroviral to Solid Formulations?

  2005cites this paper
• New antiepileptic drugs in practice – how do they perform in the real world?

  2005cites this paper
• An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.

  2005cites this paper
• The long term retention of levetiracetam in a large cohort of patients with epilepsy

  2005cites this paper
• Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.

  2005cites this paper
• Behaviour, cognition and epilepsy

  2005cites this paper
• Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

  2005cites this paper
• Improving the lives of patients with medically refractory epilepsy by electrical stimulation of the nervous system

  2005cites this paper
• Neurostimulation for Epilepsy Treatment

  2005cites this paper
• Comprehensive Care of the Epilepsy Patient—Control, Comorbidity, and Cost

  2004cites this paper
• Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

  2004cites this paper
• Daytime Sleepiness in Epilepsy Patients Receiving Topiramate Monotherapy

  2004cites this paper
• Vagus nerve stimulation for pharmacoresistant epilepsy: clinical symptoms with end of service.

  2004cites this paper
• Comprehensive care of the epilepsy patient--control, comorbidity, and cost.

  2004cites this paper
• A static magnetic field modulates severity of audiogenic seizures and anticonvulsant effects of phenytoin in DBA/2 mice.

  2003cites this paper
• Reinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate-frequency M50 indices.

  2003cites this paper
• Selection Criteria for the Clinical Use of the Newer Antiepileptic Drugs

  2003cites this paper
• Seizure worsening with Topiramate amongst Indians with refractory epilepsy

  2003cites this paper
• Second-generation antiepileptic medications in children: efficacy and cognitive effects

  2003cites this paper
• Observations on the Use of Vagus Nerve Stimulation Earlier in the Course of Pharmacoresistant Epilepsy: Patients With Seizures for Six Years or Less

  2003cites this paper
• Long-term experience with levetiracetam.

  2003cites this paper
• Vagus-nerve stimulation for the treatment of epilepsy.

  2002cites this paper
• Epilepsy Surgery: Indications, Approaches, and Results

  2002cites this paper
• Vagus nerve stimulation: efficacy, safety and tolerability, in patients with epilepsy

  2002cites this paper
• The promise of new antiepileptic drugs.

  2002cites this paper
• The evolving place of vagus nerve stimulation therapy.

  2002cites this paper
• Treatment outcome in patients with mesial temporal sclerosis.

  2002cites this paper
• New antiepileptic drugs: Comparative studies of efficacy and cognition

  2002cites this paper
• Long-term follow-up of topiramate and lamotrigine: a perspective on quality of life.

  2002cites this paper
• The clinical impact of new antiepileptic drugs after a decade of use in epilepsy.

  2002cites this paper
• Vagus nerve stimulation: where are we?

  2002cites this paper